Cabazitaxel in Patients with Advanced CRPC after Docetaxel-Failure. Results of Expanded Program Access (EAP) in Spain: Safety and Efficacy
Castellano, D.E., Aparicio, L.M. Anton, Esteban, E., Velasco, G., Perez, Q., Sanchez, A., Pérez-Valderrama, B., Batista, N.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33515-8
Date:
September, 2012
File:
PDF, 61 KB
2012